PHM-Exch> Webinar Invite: How Patent Monopolies on Biologics and Vaccines Work

Gargeya Telakapalli gargeya.t at phmovement.org
Wed Nov 15 10:21:27 PST 2023


*Webinar: How Patent Monopolies on Biologics and Vaccines Work*

*Wednesday, 22 November*

*8 am Brazil/ 1 pm CET/ 4.30 pm India*

*Registration- Click Here
<https://us02web.zoom.us/webinar/register/WN_1uIUSRs3RZuD89JPu_LdDA#/registration>*

Third World Network invites you to a one-hour discussion (with Q&A) on
intellectual property monopolies on biologics and vaccines.

We will be discussing the first chapter from the recent paper from
TWN+AccessIBSA: Monopolies on Biologics, including Vaccines
<https://accessibsa.org/media/2023/09/Monopolies-on-Biologics-including-Vaccines.pdf>


In the immediate aftermath of a pandemic characterised by monstrous gaps in
access to life-saving biologics and vaccines, we will discuss new findings
on how patent monopolies on biologics and vaccines operate. These findings
from the size and complexity of patent estates, to the lack of workable
patent examination guidelines, as well as the pitfalls in current
legislative capacity to override these patents. The authors of the paper
will discuss the situation in India, and speakers from Brazil, South Africa
and Switzerland will discuss the implications of these findings in the
countries they work in. The discussion will be moderated by Gopakumar
KM. The webinar will be in English.

*Featuring:*

*Gopakumar KM* is a legal advisor and senior researcher at the Third World
Network (Bangalore, India)

*Achal Prabhala *is the coordinator of the AccessIBSA project (Bangalore,
India)

*Roshan John* is a lawyer who works on intellectual property issues in
medicines (Delhi, India)

*Ramya Sheshadri* is a patent agent who works on access to medicines,
including managing the Patent Opposition database (Bangalore, India)

*Ana Claudia Oliveira* is an IP specialist at Abifina and Progenericos, two
leading consortia of API, vaccine and generic drug manufacturers (Rio de
Janeiro, Brazil)

*Candice Sehoma *is the Access Campaign Advocacy Advisor at MSF
(Johannesburg, South Africa)

*Nirmalya Syam* is the Senior Programme Officer in the Health, Intellectual
Property and Biodiversity Programme at the South Centre (Geneva,
Switzerland)

Free and open to all
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20231115/0598c825/attachment-0001.htm>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: Patent Monopolies on Biologics and Vaccines.pdf
Type: application/pdf
Size: 243094 bytes
Desc: not available
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20231115/0598c825/attachment-0001.pdf>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: Patent Monopolies on Biologics and Vaccines.jpg
Type: image/jpeg
Size: 325344 bytes
Desc: not available
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20231115/0598c825/attachment-0001.jpg>


More information about the PHM-Exchange mailing list